213 related articles for article (PubMed ID: 24440346)
21. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
22. The PPE18 protein of Mycobacterium tuberculosis inhibits NF-κB/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein.
Nair S; Pandey AD; Mukhopadhyay S
J Immunol; 2011 May; 186(9):5413-24. PubMed ID: 21451109
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1.
Yang Y; Yang L; Liang X; Zhu G
Cell Physiol Biochem; 2015; 36(4):1371-81. PubMed ID: 26159489
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoke-induced lung inflammation in COPD mediated via LTB4/BLT1/SOCS1 pathway.
Dong R; Xie L; Zhao K; Zhang Q; Zhou M; He P
Int J Chron Obstruct Pulmon Dis; 2016; 11():31-41. PubMed ID: 26730186
[TBL] [Abstract][Full Text] [Related]
25. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway.
Lee KC; Chang HH; Chung YH; Lee TY
J Ethnopharmacol; 2011 Jun; 135(3):678-84. PubMed ID: 21497192
[TBL] [Abstract][Full Text] [Related]
26. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
27. Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses.
Sakurai H; Tashiro K; Kawabata K; Yamaguchi T; Sakurai F; Nakagawa S; Mizuguchi H
J Immunol; 2008 Apr; 180(7):4931-8. PubMed ID: 18354218
[TBL] [Abstract][Full Text] [Related]
28. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1.
Wang P; Hou J; Lin L; Wang C; Liu X; Li D; Ma F; Wang Z; Cao X
J Immunol; 2010 Nov; 185(10):6226-33. PubMed ID: 20937844
[TBL] [Abstract][Full Text] [Related]
29. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
[TBL] [Abstract][Full Text] [Related]
30. Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance.
Sachithanandan N; Graham KL; Galic S; Honeyman JE; Fynch SL; Hewitt KA; Steinberg GR; Kay TW
Diabetes; 2011 Aug; 60(8):2023-31. PubMed ID: 21646388
[TBL] [Abstract][Full Text] [Related]
31. Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice.
Recio C; Oguiza A; Mallavia B; Lazaro I; Ortiz-Muñoz G; Lopez-Franco O; Egido J; Gomez-Guerrero C
Basic Res Cardiol; 2015 Mar; 110(2):8. PubMed ID: 25604439
[TBL] [Abstract][Full Text] [Related]
32. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
[TBL] [Abstract][Full Text] [Related]
33. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression.
Su L; Sun Y; Ma F; Lü P; Huang H; Zhou J
Immunol Lett; 2009 Aug; 125(2):151-5. PubMed ID: 19607861
[TBL] [Abstract][Full Text] [Related]
34. Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice.
Inagaki-Ohara K; Sasaki A; Matsuzaki G; Ikeda T; Hotokezaka M; Chijiiwa K; Kubo M; Yoshida H; Nawa Y; Yoshimura A
Gut; 2006 Feb; 55(2):212-9. PubMed ID: 16120757
[TBL] [Abstract][Full Text] [Related]
35. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
Jang JY; Jeon YK; Lee CE; Kim CW
Int J Oncol; 2013 Feb; 42(2):574-82. PubMed ID: 23242177
[TBL] [Abstract][Full Text] [Related]
36. CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
Sahay B; Patsey RL; Eggers CH; Salazar JC; Radolf JD; Sellati TJ
PLoS Pathog; 2009 Dec; 5(12):e1000687. PubMed ID: 20011115
[TBL] [Abstract][Full Text] [Related]
37. TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages.
Zheng S; Hedl M; Abraham C
J Immunol; 2015 Feb; 194(4):1928-37. PubMed ID: 25567680
[TBL] [Abstract][Full Text] [Related]
38. Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages.
Muratsu D; Yoshiga D; Taketomi T; Onimura T; Seki Y; Matsumoto A; Nakamura S
PLoS One; 2013; 8(7):e67906. PubMed ID: 23874464
[TBL] [Abstract][Full Text] [Related]
39. SOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophages.
Reichard AC; Cheemarla NR; Bigley NJ
J Interferon Cytokine Res; 2015 Jan; 35(1):32-41. PubMed ID: 24956148
[TBL] [Abstract][Full Text] [Related]
40. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation.
Davey GM; Heath WR; Starr R
Tissue Antigens; 2006 Jan; 67(1):1-9. PubMed ID: 16451196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
